| Three Months Ended March 31, 2025 | |||||||||||||||||
| In millions except margin | JBT | Marel | Total | ||||||||||||||
| Revenue | $ | 409 | $ | 445 | $ | 854 | |||||||||||
Adjusted EBITDA(1) | 61 | 51 | 112 | ||||||||||||||
| Adjusted EBITDA margin | 14.9% | 11.5% | 13.1% | ||||||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| In millions except margin | JBT | Marel (2) | Total | ||||||||||||||
| Revenue | $ | 392 | $ | 449 | $ | 841 | |||||||||||
Adjusted EBITDA(1) | 57 | 43 | 100 | ||||||||||||||
| Adjusted EBITDA margin | 14.6% | 9.6% | 11.9% | ||||||||||||||
| Guidance | |||||
| $ millions except EPS | Q2 2025 | ||||
| Revenue | $885 - $915 | ||||
| Income from continuing operations | $10 - $20 | ||||
Adjusted EBITDA(1) margin | 14.50 - 15.25% | ||||
| GAAP EPS | $0.20 - $0.40 | ||||
Adjusted EPS(1) | $1.20 - $1.40 | ||||
| (1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. | |||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||
| (Unaudited and in millions, except per share data) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Revenue | $ | 854.1 | $ | 392.3 | |||||||
| Cost of sales | 561.6 | 252.0 | |||||||||
| Gross profit | 292.5 | 140.3 | |||||||||
| Gross profit margin | 34.2% | 35.8% | |||||||||
| Selling, general and administrative expense | 281.7 | 103.7 | |||||||||
| Research and development | 33.6 | 6.4 | |||||||||
| Restructuring expense | 10.6 | 1.1 | |||||||||
| Operating (loss) income | (33.4) | 29.1 | |||||||||
| Operating (loss) income margin | (3.9)% | 7.4% | |||||||||
| Pension expense, other than service cost | 146.8 | 1.0 | |||||||||
| Other income | 2.0 | — | |||||||||
| Interest expense (income), net | 41.0 | (2.8) | |||||||||
| (Loss) income from continuing operations before income taxes | (219.2) | 30.9 | |||||||||
| Income tax provision | (46.2) | 8.1 | |||||||||
| Equity in net earnings of unconsolidated affiliate | — | (0.1) | |||||||||
| (Loss) income from continuing operations | (173.0) | 22.7 | |||||||||
| Income from discontinued operations, net of taxes | — | 0.1 | |||||||||
| Net (loss) income | $ | (173.0) | $ | 22.8 | |||||||
| Basic (loss) earnings per share from: | |||||||||||
| Continuing operations | $ | (3.35) | $ | 0.71 | |||||||
| Discontinued operations | — | — | |||||||||
| Net (loss) income | $ | (3.35) | $ | 0.71 | |||||||
| Diluted (loss) earnings per share from net income from: | |||||||||||
| Continuing operations | $ | (3.35) | $ | 0.71 | |||||||
| Discontinued operations | — | — | |||||||||
| Net (loss) income | $ | (3.35) | $ | 0.71 | |||||||
| Weighted average shares outstanding: | |||||||||||
| Basic | 51.7 | 32.0 | |||||||||
| Diluted | 51.7 | 32.2 | |||||||||
| Other business information from continuing operations: | |||||||||||
| Inbound orders | 916.1 | 388.5 | |||||||||
| Orders backlog | 1,310.5 | 663.6 | |||||||||
| JBT MAREL CORPORATION | |||||||||||||||||||||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||||||||||||||||||||
| RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE | |||||||||||||||||||||||||||||
| (Unaudited and in millions, except per share data) | |||||||||||||||||||||||||||||
| Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |||||||||||||||||||||||||
| (Loss) income from continuing operations | $ | (173.0) | $ | (6.9) | $ | 38.1 | $ | 30.7 | $ | 22.7 | |||||||||||||||||||
| Non-GAAP adjustments | |||||||||||||||||||||||||||||
Restructuring related costs(1) | 10.6 | 0.3 | (0.2) | 0.2 | 1.1 | ||||||||||||||||||||||||
M&A related costs(2) | 74.4 | 53.3 | 12.9 | 14.5 | 5.2 | ||||||||||||||||||||||||
| Amortization of bridge financing debt issuance cost | 12.4 | 4.7 | 1.2 | 1.2 | — | ||||||||||||||||||||||||
| Acquisition related amortization and depreciation | 41.7 | 11.4 | 11.0 | 11.1 | 11.1 | ||||||||||||||||||||||||
Impact on tax provision from Non-GAAP adjustments(3) | (31.0) | (16.7) | (6.3) | (6.8) | (4.3) | ||||||||||||||||||||||||
| Recognition of non-cash pension plan related settlement costs | 146.9 | 23.3 | — | — | — | ||||||||||||||||||||||||
| Impact on tax provision from non-cash pension plan related settlement costs | (37.1) | (6.0) | — | — | — | ||||||||||||||||||||||||
| Discrete tax adjustment from M&A activity | 5.4 | — | — | — | — | ||||||||||||||||||||||||
| Deferred tax benefit related to an internal reorganization | — | — | — | (8.8) | — | ||||||||||||||||||||||||
| Adjusted income from continuing operations | $ | 50.3 | $ | 63.4 | $ | 56.7 | $ | 42.1 | $ | 35.8 | |||||||||||||||||||
| (Loss) income from continuing operations | $ | (173.0) | $ | (6.9) | $ | 38.1 | $ | 30.7 | $ | 22.7 | |||||||||||||||||||
| Total shares and dilutive securities | 51.7 | 32.2 | 32.2 | 32.2 | 32.2 | ||||||||||||||||||||||||
| Diluted earnings per share from continuing operations | $ | (3.35) | $ | (0.21) | $ | 1.18 | $ | 0.95 | $ | 0.71 | |||||||||||||||||||
| Adjusted income from continuing operations | $ | 50.3 | $ | 63.4 | $ | 56.7 | $ | 42.1 | $ | 35.8 | |||||||||||||||||||
| Total shares and dilutive securities | 51.9 | 32.2 | 32.2 | 32.2 | 32.2 | ||||||||||||||||||||||||
| Adjusted diluted earnings per share from continuing operations | $ | 0.97 | $ | 1.97 | $ | 1.76 | $ | 1.31 | $ | 1.11 | |||||||||||||||||||
(1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | |||||||||||||||||||||||||||||
(2) M&A related costs include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy. M&A related costs are excluded as they are not part of the ongoing operations of our underlying business. | |||||||||||||||||||||||||||||
(3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | |||||||||||||||||||||||||||||
| The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | |||||||||||||||||||||||||||||
| JBT MAREL CORPORATION | |||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||
| RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (Loss) income from continuing operations | $ | (173.0) | $ | 22.7 | |||||||
| Income tax provision | (46.2) | 8.1 | |||||||||
| Interest expense (income), net | 41.0 | (2.8) | |||||||||
Other financing income(1) | (2.0) | — | |||||||||
Pension expense, other than service cost(2) | 146.8 | 1.0 | |||||||||
Restructuring related costs(3) | 10.6 | 1.1 | |||||||||
M&A related costs(4) | 74.4 | 5.2 | |||||||||
Depreciation and amortization(5) | 60.6 | 22.1 | |||||||||
| Adjusted EBITDA from continuing operations | $ | 112.2 | $ | 57.4 | |||||||
| Total revenue | $ | 854.1 | $ | 392.3 | |||||||
| Adjusted EBITDA margin | 13.1% | 14.6% | |||||||||
| (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. | |||||||||||
(2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | |||||||||||
(3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | |||||||||||
(4) M&A related costs include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy. M&A related costs are excluded as they are not part of the ongoing operations of our underlying business. | |||||||||||
(5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | |||||||||||
| The above table reports EBITDA and Adjusted EBITDA, which are non-GAAP financial measures. Given the Company’s focus on growth through acquisitions, management believes EBITDA facilitates an evaluation of business performance while excluding the impact of amortization due to the step up in value of intangible assets, and the depreciation of fixed assets. We use Adjusted EBITDA internally to make operating decisions and believe that adjusted EBITDA is useful to investors as a measure of the Company’s operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | |||||||||||
| JBT MAREL CORPORATION | |||||||||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||||||||
| SEGMENT ADJUSTED EBITDA | |||||||||||||||||
| (Unaudited and in millions) | |||||||||||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| JBT | Marel | Total | |||||||||||||||
| Segment adjusted EBITDA | $ | 60.8 | $ | 51.4 | $ | 112.2 | |||||||||||
| Segment revenue | 408.8 | 445.3 | 854.1 | ||||||||||||||
| Segment adjusted EBITDA margin | 14.9% | 11.5% | 13.1% | ||||||||||||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
| (Unaudited and in millions) | |||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 101.0 | $ | 1,228.4 | |||||||
| Restricted cash | 18.0 | — | |||||||||
| Trade receivables, net of allowances | 543.9 | 335.1 | |||||||||
| Inventories | 613.5 | 233.1 | |||||||||
| Other current assets | 212.1 | 66.7 | |||||||||
| Total current assets | 1,488.5 | 1,863.3 | |||||||||
| Property, plant and equipment, net | 742.9 | 233.7 | |||||||||
| Goodwill | 2,834.1 | 769.1 | |||||||||
| Intangible assets, net | 2,621.9 | 340.9 | |||||||||
| Other assets | 311.9 | 206.8 | |||||||||
| Total assets | $ | 7,999.3 | $ | 3,413.8 | |||||||
| Liabilities and Stockholders' Equity | |||||||||||
| Short-term debt | $ | 21.4 | $ | — | |||||||
| Accounts payable, trade and other | 282.2 | 131.0 | |||||||||
| Advance and progress payments | 496.1 | 194.1 | |||||||||
| Other current liabilities | 383.7 | 210.4 | |||||||||
| Total current liabilities | 1,183.4 | 535.5 | |||||||||
| Long-term debt, less current portion | 1,966.1 | 1,252.1 | |||||||||
| Accrued pension and other post-retirement benefits, less current portion | 16.2 | 19.3 | |||||||||
| Other liabilities | 726.3 | 62.7 | |||||||||
| Common stock and additional paid-in capital | 2,727.8 | 232.8 | |||||||||
| Retained earnings | 1,358.0 | 1,535.9 | |||||||||
| Accumulated other comprehensive loss | 21.5 | (224.5) | |||||||||
| Total stockholders' equity | 4,107.3 | 1,544.2 | |||||||||
| Total liabilities and stockholders' equity | $ | 7,999.3 | $ | 3,413.8 | |||||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from continuing operating activities | |||||||||||
| Net (loss) income | $ | (173.0) | $ | 22.8 | |||||||
| Less: Income from discontinued operations, net of taxes | — | 0.1 | |||||||||
| (Loss) income from continuing operations | (173.0) | 22.7 | |||||||||
| Adjustments to reconcile income to cash provided by operating activities | |||||||||||
| Depreciation and amortization | 60.6 | 22.1 | |||||||||
| Stock-based compensation | 4.8 | 4.2 | |||||||||
| Other | 174.1 | 2.4 | |||||||||
| Changes in operating assets and liabilities | |||||||||||
| Trade accounts receivable, net | 18.0 | (14.2) | |||||||||
| Inventories | (12.9) | (13.2) | |||||||||
| Accounts payable, trade and other | 20.9 | 8.6 | |||||||||
| Advance and progress payments | 31.8 | (7.9) | |||||||||
| Other - assets and liabilities, net | (89.9) | (14.3) | |||||||||
| Cash provided by continuing operating activities | 34.4 | 10.4 | |||||||||
| Cash flows from continuing investing activities | |||||||||||
| Acquisitions, net of cash acquired | (1,746.0) | — | |||||||||
| (Payments) proceeds from sale of AeroTech, net | (0.2) | 2.8 | |||||||||
| Capital expenditures | (20.0) | (10.5) | |||||||||
| Other | 0.6 | 0.5 | |||||||||
| Cash required by continuing investing activities | (1,765.6) | (7.2) | |||||||||
| Cash flows from continuing financing activities | |||||||||||
| Net payments of domestic credit facilities, net of debt issuance costs | (187.6) | — | |||||||||
| Proceeds from Term Loan B, net of debt issuance costs | 890.4 | — | |||||||||
| Settlement of deal contingent hedge | (42.5) | — | |||||||||
| Dividends | (5.3) | (3.2) | |||||||||
| Other | (33.6) | (2.9) | |||||||||
| Cash provided (required) by continuing financing activities | 621.4 | (6.1) | |||||||||
| Net decrease in cash and cash equivalents from continuing operations | (1,109.8) | (2.9) | |||||||||
| Net cash required by discontinued operations | — | (0.2) | |||||||||
| Effect of foreign exchange rate changes on cash and cash equivalents | 0.4 | (1.2) | |||||||||
| Net decrease in cash and cash equivalents | (1,109.4) | (4.3) | |||||||||
| Cash and cash equivalents from continuing operations, beginning of period | 1,228.4 | 483.3 | |||||||||
| Add: Cash and cash equivalents from discontinued operations, beginning of period | — | — | |||||||||
| Add: Net decrease in cash and cash equivalents | (1,109.4) | (4.3) | |||||||||
| Less: Cash and cash equivalents from discontinued operations, end of period | — | — | |||||||||
| Cash and cash equivalents from continuing operations, end of period | $ | 119.0 | $ | 479.0 | |||||||
| JBT MAREL CORPORATION | |||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||
| FREE CASH FLOW | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash provided by continuing operating activities | $ | 34.4 | $ | 10.4 | |||||||
| Less: capital expenditures | 20.0 | 10.5 | |||||||||
| Plus: proceeds from disposal of assets | 0.6 | 0.5 | |||||||||
| Plus: pension contributions | 2.8 | 0.3 | |||||||||
| Free cash flow (FCF) | $ | 17.8 | $ | 0.7 | |||||||
| The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. For free cash flow purposes, we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow. Additionally, we exclude the income taxes on gain from sale of AeroTech as these represent one-time taxes paid on the sale of a discontinued operation that are not representative of taxes from operations. | |||||||||||
| JBT MAREL CORPORATION | |||||||||||||||||||||||||||||
| NET DEBT CALCULATION | |||||||||||||||||||||||||||||
| (Unaudited and in millions) | |||||||||||||||||||||||||||||
| As of Quarter Ended | Change From | ||||||||||||||||||||||||||||
| Q1 2025 | Q4 2024 | Q1 2024 | PQ | PY | |||||||||||||||||||||||||
| Total debt | $ | 1,987.5 | $ | 1,252.1 | $ | 647.0 | $ | 735.4 | $ | 1,340.5 | |||||||||||||||||||
| Cash and marketable securities | (101.0) | (1,228.4) | (479.0) | 1,127.4 | 378.0 | ||||||||||||||||||||||||
| Net debt | $ | 1,886.5 | $ | 23.7 | $ | 168.0 | $ | 1,862.8 | $ | 1,718.5 | |||||||||||||||||||
| JBT MAREL CORPORATION | |||||
| BANK TOTAL NET LEVERAGE RATIO CALCULATION | |||||
| (Unaudited and in millions) | |||||
| Q1 2025 | |||||
| Total debt | $ | 1,987.5 | |||
| Cash and marketable securities | (101.0) | ||||
| Net debt | 1,886.5 | ||||
| Other items considered debt under the credit agreement | 37.9 | ||||
Consolidated total indebtedness(1) | $ | 1,924.4 | |||
| Trailing twelve months Adjusted EBITDA from continuing operations | 349.8 | ||||
Pro forma EBITDA of recent acquisitions(2) | 141.2 | ||||
| Trailing twelve months pro forma adjusted EBITDA | 491.0 | ||||
| Other adjustments net to earnings under the credit agreement | 105.1 | ||||
Consolidated EBITDA(1) | $ | 596.1 | |||
| Bank total net leverage ratio (Consolidated Total Indebtedness / Consolidated EBITDA) | 3.2 | ||||
| Total net debt to trailing twelve months Adjusted EBITDA from continuing operations | 3.8 | ||||
| (1) As defined in the credit agreement. | |||||
| (2) Pro forma EBITDA related to the acquisitions in the prior twelve months | |||||
| JBT MAREL CORPORATION | |||||
| NON-GAAP FINANCIAL MEASURES | |||||
| RECONCILIATION OF DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS | |||||
| TO ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE | |||||
| (Unaudited and in cents) | |||||
| Guidance | |||||
| Q2 2025 | |||||
| Diluted earnings per share from continuing operations | $0.20 - $0.40 | ||||
| Non-GAAP adjustments | |||||
Restructuring related costs(1) | 0.21 | ||||
M&A related costs(2) | 0.35 | ||||
Acquired asset depreciation and amortization(3) | 0.79 | ||||
Impact on tax provision from Non-GAAP adjustments(5) | (0.35) | ||||
| Adjusted diluted earnings per share from continuing operations | $1.20 - $1.40 | ||||
| JBT MAREL CORPORATION | |||||
| NON-GAAP FINANCIAL MEASURES | |||||
| RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA GUIDANCE | |||||
| (Unaudited and in millions) | |||||
| Guidance | |||||
| Q2 2025 | |||||
| (Loss) from continuing operations | $10.0 - $20.0 | ||||
| Income tax provision | $3.0 - $6.0 | ||||
| Interest expense, net | ~ 27.0 | ||||
Other financing income(4) | ~ (3.0) | ||||
Restructuring related costs(1) | ~ 11.0 | ||||
M&A related costs(2) | ~ 18.0 | ||||
| Depreciation and amortization | ~ 61.0 | ||||
| Adjusted EBITDA from continuing operations | $128.0 - $140.0 | ||||
| (1) Restructuring related costs is estimated to be approximately $11 million for the second quarter of 2025. The amount has been divided by our estimate of 51.9 million total shares and dilutive securities to derive earnings per share. | |||||
| (2) M&A related costs are estimated to be approximately $18 million for the second quarter of 2025, which includes $7M of integration costs and $11M of Inventory step up. The amount has been divided by our estimate of 51.9 million total shares and dilutive securities to derive earnings per share. | |||||
| (3) Acquired asset depreciation and amortization is expected to be $41M for the second quarter of 2025, related to Purchase Price Allocation and Fixed Asset Step-up. The amount has been divided by our estimate of 51.9 million total shares and dilutive securities to derive earnings per share. | |||||
| (4) Other financing income is estimated to be approximately $3 million for the second quarter of 2025. The amount has been divided by our estimate of 51.9 million total shares and dilutive securities to derive earnings per share. | |||||
| (5) Impact on tax provision for the second quarter of 2025 was calculated using a tax rate of approximately 24 - 25%. | |||||